Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation

Hepatology

Volumn 23, Issue 5, 1996, Pages 971-976

  Schluger, Leona Kim ^a   Sheiner, Patricia A ^b   Thung, Swan N ^b   Lau, Johnson Y N ^c   Min, Albert ^a   Wolf, David C ^a   Fiel, Isabel ^b   Zhang, David ^b   Gerber, Michael A ^d   Miller, Charles M ^b   Bodenheimer Jr , Henry C ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; CYCLOSPORIN A; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; VIRUS RNA;

ADULT; ARTICLE; CHOLESTATIC HEPATITIS; FEMALE; GENOTYPE; GRAFT FAILURE; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT INFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS HEPATITIS;

EID: 15844380038     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008621177     Document Type: Article

References (25)

1. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, Combs C, et al. Recurrent and acquired hepatitis G viral infection in liver transplant recipients. Gastroenterology 1992;103: 317-322.
2. Shah G, Demetris AJ, Irish W, Scheffel J, Minims L, Van Thiel DH. Frequency and severity of HCV infection following orthotopic liver transplantation. J Hepatol 1993;18:279-283.
3. Muller H, Otto G, Goeser T, Arnold J, Pfaff E, Theilmann L. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Transplantation 1992;54:743-745.
4. Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus related cirrhosis. HEPATOLOGY 1994; 20(suppl):24S-27S.
5. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-999.
6. Lumbreras C, Delgado R, Fuertes A, Loinaz C, Iglesias J, Colina F, Aguado JM, et al. Clinical significance of hepatitis C virus (HCV) infection in liver transplant recipients. Dig Dis Sci 1994; 39:965-969.
7. Casavilla A, Mateo R, Rakela J, Irish W, Starzl TE, Fung JJ. Impact of hepatitis C viral infection on survival following primary liver transplantation under FK 506 (Prograf) [Abstract]. AASLD Single Topic Symposium. Reston, VA. March, 1995.
8. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, Ureda M, et al. The course of hepatitis C virus infection after liver transplantation. HEPATOLOGY 1994;20:1137-1143.
9. Davies SE, Portman BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJM, Williams R. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. HEPATOLOGY 1989;13:150-157.
10. Sheiner P, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, Kolesnikov V, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. HEPATOLOGY 1995;21:30-34.
11. Gerber MA, Thung SN. The diagnostic value of immunohistochemical demonstration for hepatitis viral antigens in the liver. Hum Pathol 1987;18:771-774.
12. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic active hepatitis. A comparative analysis. HEPATOLOGY 1992;15:572-577.
13. Thung SN, Gerber MA. Acute hepatitis versus cellular (acute) liver allograft rejection. In: Thung SN, Gerber MA, eds. Differential Diagnosis in Pathology; Liver Disorders. New York, Tokyo, Igaku-Shoin, 1995:92-93.
14. Thung SN, Shim KS, Carol Shieh YS, Schwartz M, Theise N, Borcich A, Katz E, et al. Hepatitis C in liver allografts. Arch Pathol Lab Med 1993;117:145-149.
15. Lau JYN, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, Perrillo RP, et al. Application of six hepatitis C virus subtyping systems to sera of patients with chronic hepatitis C in the United States. J Infect Dis 1995;171:281-289.
16. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, et al. A proposed system for nomenclature of hepatitis C viral genomes. HEPATOLOGY 1994; 19:1321-1324.
17. Martin P, Munoz SJ, Di Bisceglie AM, Rubin R, Waggoner JG, Armenti VT, Moritz MJ, et al. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. HEPATOLOGY 1990;13:719-721.
18. Ferrel LD, Wright TL, Roberts J, Ascher N, Lake J. Hepatitis C viral infection in liver transplant recipients. HEPATOLOGY 1992;16:865-876.
19. Dickson RC, Iezzoni JC, Caldwell SH, Ishitani MB, Stevenson W, McCullough CS, Driscoll C, et al. Graft failure in hepatitis C patients after liver transplantation: A distinct clinical and histological entity? [Abstract]. ASSLD Single Topic Symposium. Reston, Va. March, 1995.
20. Sallie R, Cohen AT, Tibbs CJ, Portmann B, Rayner A, O'Grady JG, Tan KG, et al. Recurrence of hepatitis C following orthotopic liver transplantation: a polymerase chain reaction and histological study. J Hepatol 1994;21:536-542.
21. Benner KG, Lee RG, Keefe EB, Lopez RR, Sasaki AW, Pinson CW. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 1992;103: 1307-1312.
22. Lim HL, Lau GKK, Davis GL, Dolson DJ, Lau JYN. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994;106: 248-251.
23. Martin P, DiBisciglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989;97:159-161.
24. Shiffman JL, Contos MJ, Luketic VA, Sanyal AJ, Purdum PP, Mills AS, Fisher RA, et al. Biochemical and histologic evaluation of recurrent hepatitis C following orhtotopic liver transplantation. Transplantation 1994;57:526-532.
25. Dousset P, Conti F, Houssin D, Calmus Y. Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver transplant recipients. N Engl J Med 1994;330:1160-1161.